ASH 43rd (2001)

Title Content type
A Phase I/II Study of Induction Chemotherapy with Daunorubicin, Cytarabine, Topotecan, and Etoposide (DATE) for De Novo, Relapsed or Refractory AML, or AML Arising from a Previous Phase of MDS in Treatment of Patients Ages 16-75. (click for details)
A Multicenter Randomized Trial by Italian Lymphoma Intergroup (ILI) Comparing High Dose Chemotherapy (HDS) with Autologous Stem Cell Transplantation (ASCT) vs Intensified Chemotherapy MegaCEOP in High Risk Diffuse Large Cell Lymphoma (DLCL): No Differenc (click for details)
A Combined Approach of Early CT Scanning and Liposomal Amphotericin B [AmBisome] Treatment Is Associated with a High Clinical Response Rate and Low Mortality in Leukemic Patients Neutropenic from Chemotherapy Who Have Invasive Pulmonary aspergillosis. (click for details)
Radioimmunotherapy (RAIT) with 131-Iodine Labeled Rituximab in Patients with B Cell NHL in a Myeloablative and Non-Myeloablative Regimen. (click for details)
CAMPATH-1H Reduces the Risk of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation and Minimally Myelosuppressive Conditioning Treatment with Low Dose Total Body Irradiation and Cyclosporine/Mycophenolate Mofetil Immuno (click for details)
Early and Late Infectious Complications Following Unrelated Cord Blood Transplantation (UCBT). (click for details)
Autologous Stem Cell Transplants Combined with Rituximab for Relapsed Follicular Lymphoma Achieve Prolonged Clinical and Molecular Remissions. (click for details)
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis. (click for details)
Elderly Patients with Aggressive Non-Hodgkin's Lymphoma (NHL): An Age Adjusted High Dose Chemotherapy (HDC) with Autologous Stem Cell Transplantation (ASCT) Allows an Adequate PBPC Yield with Low Toxicity and Promising Results. (click for details)
Post-Transplant Thrombotic Thrombocytopenic Purpura (TTP), a Complication of High Risk Myeloablative and Non-Myeloablative Transplantation, Is Not Associated with von Willebrand Factor-Cleaving Protease (vWF-CP) Deficiency. (click for details)


Subscribe to ASH 43rd (2001)